Ribometrix is a platform therapeutics company that discovers small molecule drugs to treat human diseases. . Founded by Katie Warner in 2014, Ribometrix is backed by investors that include Alexandria Venture Investments, Amgen Ventures, Hatteras Venture Partners, Illumina Ventures, and SV Health Investors and is headquartered in Greenville.